(Methanesulfonamide,N-[2-[(4S)-4,5-dihydro-4-(1-methylethyl)-2-oxazolyl]-6-methylphenyl]- )
Intermediate of Eribulin mesylate for the treatment of Breast cancer
We can provide high-quality (Methanesulfonamide,N-[2-[(4S)-4,5-dihydro-4-(1-methylethyl)-2-oxazolyl]-6-methylphenyl]- ) and its derived impurities.
-
CAS480444-15-3
-
CatalogHY-42008
-
Molecular Weight296.39
-
Molecular FormularC14H20N2O3S
-
Boc-Dap-NECAS: 160800-65-7 -
methyl 2-((2R,4aS,6S,7S,8R,8aR)-7,8- dihydroxy-6-((S,E)-1-hydroxy-3- (trimethylsilyl)allyl)octahydropyrano[3,2 -b]pyran-2-yl)acetateCAS: 871360-33-7 -
(+)-1,2-epoxyhex-5-eneCAS: 137688-20-1 -
Eribulin mesylate intermediateCAS: 157322-83-3 -
Intermediate of Eribulin mesylateCAS: 2835443-65-5 -
Intermediate of Eribulin mesylateCAS: 253128-14-2 -
Eribulin Fragment B AlcoholCAS: 157322-47-9 -
Eribulin intermediateCAS: 1960458-56-3 -
(3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl] azetidin-2-oneCAS: 1808153-91-4 -
Eribulin Fragment C-TosylCAS: 1808153-90-3 -
Eribulin mesylateCAS: 441045-17-6 -
D-xylo-Hexofuranuronic acid, 5-deoxy-1,2-O-isopropylidene-, γ-lactoneCAS: 7057-10-5 -
(S)-3-((2R,3R,4S,5S)-5-allyl-3-(benzyloxy)-4-hydroxytetrahydrofuran-2-yl)propane-1,2-diyl dibenzoateCAS: 546141-24-6 -
1,2-Propanediol, 3-[(2R,3R,4R,5S)-tetrahydro-3-hydroxy-4-[[(4-methylphenyl)sulfonyl]methyl]-5-(2-propen-1-yl)-2-furanyl]-, (2S)-CAS: 1808153-92-5 -
(3R)-2,4-Diiodo-3-methyl-1-buteneCAS: 481048-22-0 -
3-((2S,5S)-5-(3-hydroxypropyl)-4-methylenetetrahydrofuran-2-yl)propyl pivalateCAS: 2448079-78-3
